Dogwood Therapeutics, Inc.
DWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818844
No open-market purchases or sales by Dogwood Therapeutics, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $6.16M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Dogwood Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- 0 vs. Q4 2023
- Shares held
- 678.0K
- −182.2K (−21.2%) vs. Q4 2023
- Total value
- $324.9K
- −$168.5K (−34.2%) vs. Q4 2023
- New holders
- 5
- 3 more added
- Sold out
- 5
- 1 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $6.16M |
| Q1 2026 | 13 | $7.64M |
| Q4 2025 | 10 | $292.0K |
| Q3 2025 | 12 | $299.5K |
| Q2 2025 | 10 | $207.5K |
| Q1 2025 | 13 | $409.8K |
| Q4 2024 | 10 | $76.5K |
| Q3 2024 | 24 | $180.3K |
| Q2 2024 | 24 | $212.0K |
| Q1 2024 | 20 | $324.9K |
| Q4 2023 | 20 | $493.4K |
| Q3 2023 | 23 | $766.3K |
| Q2 2023 | 24 | $1.08M |
| Q1 2023 | 23 | $307.1K |
| Q4 2022 | 27 | $307.7K |
| Q3 2022 | 25 | $485.7K |
| Q2 2022 | 17 | $4.80M |
| Q1 2022 | 15 | $4.91M |
| Q4 2021 | 16 | $4.85M |
| Q3 2021 | 13 | $5.30M |
| Q2 2021 | 14 | $5.58M |
| Q1 2021 | 14 | $5.06M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Dogwood Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 208,883 | $100.1K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 174,469 | $83.6K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 52,828 | $25.3K | 0.00% | 00.0% | Unchanged |
| McCollum Christoferson Group LLC | 42,000 | $20.1K | 0.01% | +5,000+13.5% | Added |
| Raymond James & Associates | 30,000 | $14.4K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 24,035 | $11.5K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 23,363 | $11.2K | 0.00% | +23,363 | New |
| Regions Financial Corp | 20,072 | $9.62K | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 19,062 | $9.13K | 0.00% | +19,062 | New |
| Jane Street Group, LLC | 16,998 | $8.14K | 0.00% | +16,998 | New |
| Morgan Stanley | 15,000 | $7.19K | 0.00% | 00.0% | Unchanged |
| Cetera Investment Advisers | 12,101 | $5.80K | 0.00% | +12,101 | New |
| Wiley Bros.-Aintree Capital, LLC | 11,000 | $5.27K | 0.00% | 00.0% | Unchanged |
| William Howard & Co Financial Advisors Inc | 10,072 | $5.00K | 0.00% | +10,072 | New |
| Group One Trading, L.P. | 8,111 | $3.89K | 0.00% | −5,871−42.0% | Reduced |
| Tower Research Capital LLC (TRC) | 6,811 | $3.26K | 0.00% | +107+1.6% | Added |
| Cutler Group LP | 2,300 | $1.00K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 755 | $362 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 133 | $64 | 0.00% | +3+2.3% | Added |
| Royal Bank of Canada | 56 | $0 | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −206,697−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −22,760−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −17,372−100.0% | Sold out |
| Cetera Advisors LLC | 0 | $0 | 0.00% | −13,560−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,600−100.0% | Sold out |